Benjamin Parsons is an Oncology physician affiliated with Gundersen Health System. OpenAlex indexes 254 publications with 4,658 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1836 South Ave
La Crosse, WI 546015429
Telephone
608-782-7300Registry record last updated 27 Aug 2014.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genmab U.S., Inc.Program year20251 payment
- Tempus AI, IncProgram year20251 payment
- Genmab U.S., Inc.Program year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.9%Kinase inhibitor11%Jakafi35%Imbruvica33%Brukinsa13%Calquence10%Cabometyx9%Part D<11 patientsAntimetabolite8.1%Hydroxyurea100%Part D≥20 patients+ 5 more classes in this area
Dermatology
23.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor23.9%Acyclovir100%Part D≥50 patientsBlood & clotting
10.4%Vitamin K antagonist6%Warfarin Sodium100%Part D<11 patientsFactor Xa inhibitor3%Eliquis100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit
Communications Medicine
2023 - Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Cancer Research Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Christina Fitzmaurice, MD
Gundersen Health System
Lori Rosenstein, MD
Gundersen Health System
Humbert Sullivan, MD
Gundersen Health System
Anna Kitzmann, MD
Gundersen Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”